Gailutė Kirdaitė

Dr. Gailutė Kirdaitė

Department of Experimental, Preventive and Clinical Medicine, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Research in Veterinary Science
Verified
Journal Article
Closed access
Gailutė KirdaitėGailutė Kirdaitė
Gailutė Kirdaitė
LLLaima Leonaviciene
Laima Leonaviciene
RBRuta Bradunaite
Ruta Bradunaite
AVAudrius Vasiliauskas
Audrius Vasiliauskas
RRRomualdas Rudys
Romualdas Rudys
ZMZygmunt Mackiewicz
Zygmunt Mackiewicz

10 October 2023 in Bioelectrochemistry
Verified
Journal Article
Closed access
Ilona UzielienėIlona Uzielienė
Ilona Uzielienė
Anton PopovAnton Popov
Anton Popov
RVRaminta Vaičiulevičiūtė
Raminta Vaičiulevičiūtė
Gailutė KirdaitėGailutė Kirdaitė
Gailutė Kirdaitė
EBEiva Bernotiene
Eiva Bernotiene
Almira RamanavicieneAlmira Ramanaviciene
Almira Ramanaviciene

25 January 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
Almira RamanavicieneAlmira Ramanaviciene
Almira Ramanaviciene
Anton PopovAnton Popov
Anton Popov
EBEma Baliunaite
Ema Baliunaite
BBBenediktas Brasiunas
Benediktas Brasiunas
Asta Kausaite-MinkstimieneAsta Kausaite-Minkstimiene
Asta Kausaite-Minkstimiene
Ali MobasheriAli Mobasheri
Ali Mobasheri
Physiological and endocrine maintenance of a normal human growth hormone (hGH) concentration is crucial for growth, development, and a number of essential biological processes. In this study, we describe the preparation and characterization of magnetic nanoparticles coated with a gold shell (MNPs-Au). The optimal surface concentration of monoclonal anti-hGH antibodies (m-anti-hGH) on magnetic nanoparticles, as well as conditions that decrease non-specific interactions during the magneto-immunoassay, were elaborated. After the selective recognition, separation, and pre-concentration of hGH by MNPs-Au/m-anti-hGH and the hGH interaction with specific polyclonal biotin-labeled antibodies (p-anti-hHG-B) and streptavidin modified horseradish peroxidase (S-HRP), the MNPs-Au/m-anti-hGH/hGH/p-anti-hGH-B/S-HRP immunoconjugate was formed. The concentration of hGH was determined after the addition of 3,3′,5,5′-tetramethylbenzidine and hydrogen peroxide substrate solution for HRP; the absorbance at 450 nm was registered after the addition of STOP solution. The developed sandwich-type colorimetric magneto-immunoassay is characterized by a clinically relevant linear range (from 0.1 to 5.0 nmol L−1, R2 0.9831), low limit of detection (0.082 nmol L−1), and negligible non-specific binding of other antibodies or S-HRP. The obtained results demonstrate the applicability of the developed magneto-immunoassay for the concentration and determination of hGH in the serum. Additionally, important technical solutions for the development of the sandwich-type colorimetric magneto-immunoassay are discussed.

1 August 2017 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
DKDiana Karpec
Diana Karpec
RRRomualdas Rudys
Romualdas Rudys
LLLaima Leonaviciene
Laima Leonaviciene
ZMZygmunt Mackiewicz
Zygmunt Mackiewicz
RBRuta Bradunaite
Ruta Bradunaite
AVAlgirdas Venalis
Algirdas Venalis

1 September 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
Viktorija AleksiukViktorija Aleksiuk
Viktorija Aleksiuk
JBJustinas Baleišis
Justinas Baleišis
Gailutė KirdaitėGailutė Kirdaitė
Gailutė Kirdaitė
Ilona UzielienėIlona Uzielienė
Ilona Uzielienė
JDJaroslav Denkovskij
Jaroslav Denkovskij
EBEiva Bernotiene
Eiva Bernotiene
Osteoarthritis (OA) ranks as the prevailing type of arthritis on a global scale, for which no effective treatments are currently available. Arterial hypertension is a common comorbidity in OA patients, and antihypertensive drugs, such as nifedipine (NIF), may affect the course of OA progression. The aim of this preclinical study was to determine the effect of nifedipine on healthy and OA cartilage, depending on its route of administration. In this study, we used the destabilization of medial meniscus to develop a mouse model of OA. Nifedipine was applied per os or intraarticularly (i.a.) for 8 weeks to both mice with OA and healthy animals. Serum biomarker concentrations were evaluated using the Luminex platform and alterations in the knee cartilage were graded according to OARSI histological scores and investigated immunohistochemically. Nifedipine treatment per os and i.a. exerted protective effects, as assessed by the OARSI histological scores. However, long-term nifedipine i.a. injections induced the deterioration of healthy cartilage. Lubricin, cartilage intermediate layer matrix protein (CILP), collagen type VI (COLVI), CILP, and Ki67 were upregulated by the nifedipine treatment. Serum biomarkers MMP-3, thrombospondin-4, and leptin were upregulated in the healthy groups treated with nifedipine, while only the levels of MMP-3 were significantly higher in the OA group treated with nifedipine per os compared to the untreated group. In conclusion, this study highlights the differential effects of nifedipine on cartilage integrity, depending on the route of administration and cartilage condition.

1 February 2025 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
UKUrsule Kalvaityte
Ursule Kalvaityte
EBEdvardas Bagdonas
Edvardas Bagdonas
Gailutė KirdaitėGailutė Kirdaitė
Gailutė Kirdaitė
Asta Kausaite-MinkstimieneAsta Kausaite-Minkstimiene
Asta Kausaite-Minkstimiene
Ilona UzielienėIlona Uzielienė
Ilona Uzielienė
EBEiva Bernotiene
Eiva Bernotiene
Purpose: For the diagnosis of various diseases, simultaneous sensitive detection of multiple biomarkers using low sample volumes is needed. The purpose of the present research was to develop sensitive multiplex detection model of QD-based ELISA (QLISA), through the spectroscopic QD-analyte complex measurements in microvolume liquid droplets on a glass microslide. Methods: QLISA was used for the detection of cartilage oligomeric matrix protein (COMP) and human growth hormone (hGH) as model analytes. The QLISA detection method included the formation of complexes consisting of analyte antigens, biotinylated antibodies and streptavidin-coated QDs. A specific immune-complex disassembling solution was used to dissociate analyte-antibody complexes from the bottom of the 96-well plate. After dissociation, the samples were diluted with PBS, and 2 μL transferred to a reusable glass slide for fluorescence (FL) scan. Results: The alkaline immune-complex disassembling solution that most efficiently amplified QDs FL within a prolonged 17 h time was selected. Comparison of median fluorescence intensity (MFI) of 50 nM COMP, 25 nM COMP, and 5 nM COMP detection using QD655 with the dilution of the detached samples with PBS and without dilution resulted in significant MFI differences in all cases. The FL signal readouts from QD655 in the microvolume format were from 10 to 40 times stronger than those measured directly from a 96-well plate QLISAs. In duplex analysis, two analytes COMP and hGH were measured using different QD605 and QD525 in the same well. In the respectful 96-well plate QLISA format, two different analyte concentrations can be hardly distinguishable, but the transfer to micro-volumetric detection on the glass slide highly increased the signal strength according to green and red FL intensity of QDs. Conclusion: Our method significantly enhances detection sensitivity, as compared to measured in parallel QLISAs in a 96 well plate format, enables multiplexing and may prove very valuable for samples of limited volumes.